Loading clinical trials...
Loading clinical trials...
Glucose Control in Pre-Diabetic Renal Transplant Patients: Efficacy and Safety of Vildagliptin and Pioglitazone
Conditions
Interventions
Vildagliptin
Pioglitazone
+1 more
Locations
1
Austria
Allgemeines Krankenhaus der Stadt Wien, Universitätskliniken
Vienna, Austria
Start Date
December 1, 2009
Primary Completion Date
November 1, 2011
Completion Date
November 1, 2011
Last Updated
December 5, 2011
NCT07415421
NCT06958796
NCT07294547
NCT07224763
NCT06972069
NCT05234463
Lead Sponsor
Marcus Saemann
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions